Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: Applicability and accuracy of the exercise stress test

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 649-654

  Bacci, S ^a   Villella, M ^a   Villella, A ^a   Langialonga, T ^a   Grilli, M ^a   Rauseo, A ^a   Mastroianno, S ^a   De Cosmo, S ^a   Fanelli, R ^a   Trischitta, V ^a,b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE DURATION; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT DEPRESSION;

EID: 0036856155     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470649     Document Type: Article

References (29)

1. American Diabetes Association, Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998 21 1551-1559.
2. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on exercise testing). Journal of the American College of Cardiology 1997 30 260-311.
3. Brun E, Nelson RG, Bennett PH, Imperatore G, Zoppini G, Verlato G et al. Diabetes duration and cause specific mortality in the Verona Diabetes Study. Diabetes Care 2000 23 1119-1123.
4. Stammer J, Vaquero O, Nekton JD & Wentworth D. Diabetes, other risk factors, and 12-years cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993 16 434-444.
5. Kannel WB. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. American Heart Journal 1985 110 1100-1107.
6. Sniderman A, Michel C & Racine N. Heart disease in patients with diabetes mellitus. Journal of Clinical Epidemiology 1992 45 1357-1370.
7. Uusitupa MI, Niskanen LK, Siitonen O, Voutilanen E & Pyorala K. Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non insulin-dependent) diabetic and non diabetic subjects. Diabetologia 1993 36 1175-1184.
8. DeStafano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF et al. Risk factors for coronary heart disease mortality among persons with diabetes. Annals of Epidemiology 1993 3 27-34.
9. Margolis JR, Kannel WS, Feinleib M, Dawber TR & McNamra PM. Clinical features of unrecognized myocardial infarction: Silent and asymptomatic: eighteen-year follow-up study; the Framingham Study. American Journal of Cardiology 1973 32 1-7.
10. Kannel WB & Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham Study. New England Journal of Medicine 1984 311 1144-1147.
11. Callaham PR, Froelicher VF, Klein J, Risch M, Dubach P & Friis R. Exercise induced silent ischaemia: age, diabetes mellitus, previous myocardial infarction and prognosis. Journal of the American College of Cardiology 1989 14 1175-1180.
12. Weiner DA, Ryan TJ, Parson L, Fisher LD, Chaitman BR, Sheffield LT et al. Significance of silent myocardial ischaemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) registry. American Journal of Cardiology 1991 68 729-734.
13. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou P, Cordonnier D et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Diabetes Care 1999 22 19-26.
14. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. British Medical Journal 1990 301 92-95.
15. Naka M, Hiramtsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. American Heart Journal 1992 123 46-53.
16. Multiple Risk Factor Intervention Trial Research Group. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. American Journal of Cardiology 1985 55 16-24.
17. Marchant B, Umachandran V, Stevenson R, Kopelman PG & Timmis AD. Silent myocardial ischaemia. Role of subclinical neuropathy in patients with and without diabetes. Journal of the American College of Cardiology 1993 22 1433-1437.
18. Ahluwalia G, Jain P, Chugh SK, Wasir HS & Kaul U. Silent myocardial ischaemia in diabetics with normal autonomic function. International Journal of Cardiology 1995 48 147-153.
19. Delenne BJ, Savin B, Habib G, Bory M, Vague P & Lassmann-Vague V. Silent myocardial ischaemia in patients with diabetes. Who to screen? Diabetes Care 1999 22 1396-1400.
20. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E et al. Angina and exertional myocardial ischaemia in diabetic and non diabetic patients: assessment by exercise thallium, scintigraphy. Annals of Internal Medicine 1988 108 170-175.
21. Airaksinen KE. Silent coronary artery disease in diabetes - a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 2001 44 259-266.
22. Zoneraich S, Silverman G & Zonersich O. Primary myocardial disease, diabetes mellitus and small vessel disease. American Heart Journal 1980 100 754-755.
23. Blumental HT, Alex M & Golderberg S. A study of lesions of the intramural coronary artery branches in diabetes mellitus. Archives of Pathology 1960 70 27-42.
24. Nitemberg A, Valensi P, Sachs R, Dali M, Aptecar E & Attali JR. Impairment of coronary vascular reserve and Ach-induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993 42 1017-1025.
25. Nasher P, Brown R, Askarsson H, Winniford M & Rossen J. Maximal coronary reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 1995 91 635-640.
26. Milan Study on Atherosclerosis and Diabetes (MISAD) group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerosis risk factors in non insulin-dependent diabetes mellitus. American Journal of Cardiology 1997 79 134-139.
27. Lemp GF, Zwaag RV, Hughes JP, Maddock V, Kroetz F, Ramanathan KB et al. Association between the severity of diabetes mellitus and coronary arterial atherosclerosis. American Journal of Cardiology 1987 60 1015-1019.
28. Krolewsky AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. American Journal of Cardiology 1987 59 750-755.
29. Earle KA, Mishra M, Morocutti A, Barnes D, Stephens E, Chambers J & Viberti GC. Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 1996 39 854-856.